Skip to main content
Fig. 4 | BMC Pharmacology and Toxicology

Fig. 4

From: Radotinib attenuates TGFβ -mediated pulmonary fibrosis in vitro and in vivo: exploring the potential of drug repurposing

Fig. 4

Metabolic change analysis. Partial least-squares discriminant analysis (PLS-DA) score plots of control (UN: untreated group), treated with bleomycin (Bl: 5 mg/kg of bleomycin), and treated Bl + Rb (treated with 5 mg/kg of bleomycin and administered with 30 mg/kg of radotinib) groups. PLS-DA score plots were derived from metabolite ions acquired from ESI- (A) and ESI+ (B) modes (n = 4)

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us